PENTIXAPHARM HOLDING AG (PTP.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:PTP - DE000A40AEG0 - Common Stock
PTP.DE Key Statistics, Chart & Performance
The current stock price of PTP.DE is 1.614 EUR. In the past month the price increased by 8.46%. In the past year, price decreased by -46.82%.
PTP.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL.PA | ESSILORLUXOTTICA | 40.35 | 128.39B | ||
| 1EL.MI | ESSILORLUXOTTICA | 38.33 | 121.95B | ||
| ESL.DE | ESSILORLUXOTTICA | 38.27 | 121.76B | ||
| GBT.PA | GUERBET | 24.3 | 187.32M | ||
| ALCJ.PA | CROSSJECT | N/A | 123.88M | ||
| AFME.PA | AFFLUENT MEDICAL SA | N/A | 74.77M |
Related stock screener links
About PTP.DE
Company Profile
Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company is headquartered in Berlin, Berlin and currently employs 64 full-time employees. The company went IPO on 2024-10-03. The firm focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. The company is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.
Company Info
PENTIXAPHARM HOLDING AG
Robert-Roessle-Strasse 10
Berlin BERLIN DE
Employees: 64
Phone: 493094893220
PENTIXAPHARM HOLDING AG / PTP.DE FAQ
What does PENTIXAPHARM HOLDING AG do?
Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company is headquartered in Berlin, Berlin and currently employs 64 full-time employees. The company went IPO on 2024-10-03. The firm focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. The company is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.
What is the stock price of PENTIXAPHARM HOLDING AG today?
The current stock price of PTP.DE is 1.614 EUR. The price increased by 1.51% in the last trading session.
Does PENTIXAPHARM HOLDING AG pay dividends?
PTP.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of PTP stock?
PTP.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the Price/Earnings (PE) ratio of PENTIXAPHARM HOLDING AG (PTP.DE)?
PENTIXAPHARM HOLDING AG (PTP.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.86).
Would investing in PENTIXAPHARM HOLDING AG be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PTP.DE.
What is PENTIXAPHARM HOLDING AG worth?
PENTIXAPHARM HOLDING AG (PTP.DE) has a market capitalization of 40.03M EUR. This makes PTP.DE a Nano Cap stock.
PTP.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PTP.DE. When comparing the yearly performance of all stocks, PTP.DE is a bad performer in the overall market: 94.74% of all stocks are doing better.
PTP.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PTP.DE. While PTP.DE has a great health rating, there are worries on its profitability.
PTP.DE Financial Highlights
Over the last trailing twelve months PTP.DE reported a non-GAAP Earnings per Share(EPS) of -0.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -59.32% | ||
| ROE | -69.4% | ||
| Debt/Equity | 0 |
PTP.DE Forecast & Estimates
5 analysts have analysed PTP.DE and the average price target is 11.95 EUR. This implies a price increase of 640.67% is expected in the next year compared to the current price of 1.614.